Pantarhei Bioscience BV | Boulevard 17 | 3707 BK Zeist | The Netherlands
Phone: +31 (0)30 6 985 020 | Email: firstname.lastname@example.org
The information contained in this website is for general information purposes only. The information is provided by Pantarhei Bioscience and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
11th Congress of the European Menopause and Andropause Society, May 22-24, 2017, Amsterdam, the Netherlands/in News
On Wednesday May 24, 2017 Pantarhei sponsored a symposium entitled “Estrogens for breast- and prostate cancer treatment”. Lectures were presented by Herjan Coelingh Bennink (High dose estrogens for breast cancer), Carole Verhoeven (Estetrol for breast cancer) and Yvette Zimmerman (Estetrol for prostate cancer). The session was chaired by Ludwig Kiesel and Cobi Reisman.
ENDO 2017, April 1-4, 2017 Orlando, USA, Press Release/in News
The first weekend of April, Yvette Zimmerman, COO and Ellen Dutman, CRA at Pantarhei attended the ENDO congress in Orlando, USA, which is organised by the Endocrine Society. The results from a clinical study with estetrol in healthy men were presented in a poster session.
For more information please read the press release of the Endocrine Society. Read more
BioCapital Europe conference March 15, 2017, Amsterdam, the Netherlands/in News
The CEO of Pantarhei, Herjan Coelingh Bennink, will be presenting at the BioCapital Europe Conference on March 15, 2017 in Amsterdam. An ideal opportunity to meet us and discuss possibilities to collaborate, partner with or invest in Pantarhei’s programmes.